XML 18 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Income (Loss) - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenues € 39,183 € 35,746 € 35,611
Cost of sales (22,266) (20,938) (19,200)
Gross profit 16,917 14,808 16,411
Research and development expenses (4,088) (3,881) (3,868)
Selling and marketing expenses (10,551) (9,526) (8,856)
General and administrative expenses (3,593) (3,428) (3,296)
Income (loss) from operations (1,315) (2,027) 392
Financial income (expense), net 797 2,643 3,949
Foreign Currency exchange (losses) gains, net 538 (909) 103
Income (loss) before taxes 20 (293) 4,444
Income tax (expense) credit (358) (388) (602)
Net income (loss) € (338) € (681) € 3,842
Basic income (loss) per share (in EUR per share) € (0.01) € (0.02) € 0.14
Diluted income (loss) per share (in EUR per share) € (0.01) € (0.02) € 0.13
Basic Weighted average shares outstanding (in shares) 28,997,866 28,961,928 27,823,313
Diluted Weighted average shares outstanding (in shares) 28,997,866 28,961,928 29,365,583
Product [Member]      
Revenues € 25,070 € 22,580 € 24,045
Cost of sales (14,053) (13,170) (12,288)
HIFU Treatments and Devices Leased [Member]      
Revenues 5,086 5,095 4,906
Cost of sales (2,557) (2,667) (2,527)
Parts and Services [Member]      
Revenues 9,007 8,011 6,628
Cost of sales (5,655) (5,101) (4,385)
Product and Services, Excluding Other [Member]      
Revenues 39,163 35,686 35,579
Product and Service, Other [Member]      
Revenues € 19 € 60 € 32